Navigating Breast Cancer Survivorship
Claim This Podcastby AONN
Podcast Overview
<p>The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to present an exclusive 3-part podcast series, “Navigating Breast Cancer Survivorship.” The series will provide peer-to-peer perspectives on managing fear of recurrence and side effect management; genomic testing and patient education; and financial challenges in survivorship.</p>
Language
🇺🇲
Publishing Since
10/29/2024
Reach the team behind Navigating Breast Cancer Survivorship
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
December 2, 2024
Navigating Billing and Insurance in Survivorship
Michelle L. Kirschner and Stephanie M. Hoopes explore billing and insurance complexities faced by breast cancer survivors, offering insights for navigating financial aspects of survivorship in this interview.
November 11, 2024
Genomic Testing In Survivorship
Michelle L. Kirschner and Stephanie M. Hoopes explore genomic testing's role in breast cancer survivorship, offering insights on managing recurrence fears and side effects in this interview.
October 29, 2024
Balancing Risk of Recurrence vs Side Effects From Anti-Estrogen Therapy
Michelle L. Kirschner and Stephanie M. Hoopes explore balancing the risk of breast cancer recurrence against the side effects of anti-estrogen therapy, offering peer-to-peer perspectives on survivorship.
3 total episodes available
Recent guests on Navigating Breast Cancer Survivorship
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Michelle L Kirschner
Guest
Stephanie M Hoopes
Guest
Deep-dive analytics for Navigating Breast Cancer Survivorship
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Navigating Breast Cancer Survivorship?
<p>The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to present an exclusive 3-part podcast series, “Navigating Breast Cancer Survivorship.” The series will provide peer-to-peer perspectives on managing fear of recurrence and side effect management; genomic testing and patient education; and financial challenges in survivorship.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.